Related Post
Prepare Migraine headache It is a problem that affects many people, and the medications used to treat it vary. Which is better, cheap or expensive medicines?
Researchers at the Norwegian Headache Research Center in Norway answered this question, in a study recently published in the European Journal of Neurology.
Migraine is more than just a headache, it often accompanies it nausea Vomiting, sensitivity to light and sensitivity to sound. Chronic migraines can be disabling, especially for women.
Suitable treatment
However, migraine patients often take a long time to find a treatment that works for them.
The researchers used data from the Norwegian Prescription Registry to look at which medications best prevent migraines.
The researchers used national registry data from 2010 to 2020 to estimate the treatment effect. They measured this by looking at the consumption of acute migraine medications before and after starting preventive treatment, and investigating how long people with migraines used different preventive treatments. The study included more than 100,000 migraine patients.
In general, so-called beta blockers are used as the first choice to prevent migraine attacks, but researchers have found that 3 medications in particular have the best preventive effect (i.e. in preventing a migraine attack), which are:
- CGRP inhibitors
- Amitriptyline
- simvastatin
Professor Marti-Helen Björk at the Department of Clinical Medicine at the University of Bergen said, “The last two drugs are also approved drugs to treat depression and chronic pain (amitriptyline) and high cholesterol (simvastatin), respectively, while CGRP inhibitors were developed and used specifically to treat headaches.” Chronic migraine.
In terms of price, CGRP inhibitors are more expensive than other drugs, while amitriptyline and simvastatin are less expensive.
The study results mean that cheaper migraine treatments are just as effective as more expensive ones.
It is worth noting that in 2021, the cost of using CGRP inhibitors in Norway amounted to 500 million Norwegian kroner (about 46.5 million dollars).
“Our analysis shows that some cheaper medicines can have a similar therapeutic effect to more expensive medicines,” Professor Björk added. “This could be of great importance for both the patient population and Norwegian healthcare,” says Björk.
What do we know about migraines?
A migraine is a severe headache that may last for hours or even days. It affects women more than men, and it is believed that several factors such as Genetics Electrical activity in the brain and the neurotransmitter serotonin play a role.
A migraine is also known as a migraine. The headache usually begins in the forehead, on the side of the head, or around the eyes, and is sharp or pulsating, and the headache usually gets worse gradually, and the slightest movement, bright light, or loud sound may also make it worse. The affected person may also feel nauseous and may vomit.
Migraines may occur once or twice a year, or they may occur daily. Women are more susceptible to migraines than men. According to the National Health Service in the United Kingdom, migraines affect one in 5 women, compared to one in 15 men.
Globally, more than 10% of the world’s population suffers from migraines, according to the National Foundation for Neurological Disorders and Stroke in United States of America.
A headache attack may be preceded by what is known as an “aura”, which are symptoms that include visual disturbances, such as pulsating lights, zigzag lines, or temporary loss of vision.
